Cargando...
Development of Sustained Release “NanoFDC (Fixed Dose Combination)” for Hypertension – An Experimental Study
OBJECTIVES: The present study was planned to formulate, characterize and evaluate the pharmacokinetics of a novel “NanoFDC” comprising three commonly prescribed anti-hypertensive drugs, hydrochlorothiazide (a diuretic), candesartan (ARB) and amlodipine (a calcium channel blocker). BASIC METHODS: The...
Guardado en:
| Publicado en: | PLoS One |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Public Library of Science
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4457799/ https://ncbi.nlm.nih.gov/pubmed/26047011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0128208 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|